Playing catchup: how digitilization will impact european utilities
The energy industry is in flux as utilities scramble to adapt to digitalization, major shifts in the energy mix and the rise of storage systems. In this paper we analyze what these trends mean for incumbents and look ahead to the future of the European energy market.
The next big growth idea
Where will FMCG, healthcare and technology groups find growth now? Our new white paper argues that as we transition to a new world of personalized consumption, it all depends on data-driven innovation and M&A.
Bryan, Garnier & Co strengthens its Business Services franchise with the hiring of Stanislas de Gmeline as Managing Director
PARIS, December 19, 2017 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is delighted to welcome Stanislas de Gmeline to its European Business Services franchise.
With over 18 years of experience in global finance, Stanislas will be responsible for LBO origination, and help Bryan, Garnier & Co to reinforce its footprint within the Business Services sector. He will be based in Paris.
Before joining Bryan, Garnier & Co, Stanislas, spent 10 years in investment banking working for both bulge brackets banks (HSBC, Credit Suisse) and independent M&A boutiques in London and Paris, as well as 7 years in venture capital and small-cap LBO investment for private banks. He is also the Founder of Valbrenne Finance, an independent Corporate Finance advisory boutique dedicated to entrepreneurs and family offices.
Greg Revenu, Managing Partner, Bryan, Garnier & Co comments: “I am delighted to have Stanislas join our Business Services franchise. He brings with him not only a solid expertise in Investment Banking (M&A, ECM, Private Banking, Private Equity investment and Corporate Finance advisory) but also an entrepreneurial spirit – a perfect match for the Bryan, Garnier’s business ambitions and culture”.
Stanislas adds: “Bryan, Garnier & Co is a unique, truly European financial services firm combining the depth and breadth of fully-integrated investment banks with the flexibility of entrepreneurial partnerships, thus providing people with rare opportunities to help clients achieve ambitious targets. I really look forward to assisting its teams strengthen the firm’s footprint in the field of Business Services and with financial sponsors alike”.
Stanislas holds a Master of Business Administration from INSEAD as well as a Master’s Degree in Political Sciences from Sciences Po, in Paris where he majored in Economics and Finance.
Bryan, Garnier & Co grows its TMT franchise with the hiring of Charlie Pujo as Director
PARIS, December 6 2017 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is delighted to welcome Charlie Pujo to its Technology, Media & Telecoms team.
With over 10 years of experience in financial and strategic advisory services notably in M&A, Charlie, will be responsible for the development of the software and technology practice of Bryan, Garnier & Co. He will assist the TMT team in sourcing and executing ECM and M&A mandates for European growth tech companies, private equity funds and corporates. He will be based in Paris.
Prior to joining Bryan, Garnier & Co, Charlie worked as an investment banker for Société Générale, (London) in their TMT, Aerospace & Defense – M&A advisory services – where he was responsible for the development of the Technology and Aerospace & Defense franchise. Charlie has also previously held positions at Qwant.com where he was Strategic Advisor and Deputy CEO, Arma Partners and Lehman Brothers.
Olivier Beaudouin, Partner, Bryan, Garnier & Co, Paris comments: "I am delighted to have Charlie join the Technology, Media and Telecoms franchise, strengthening our capacity to continue to support fast growth companies in Europe".
Charlie adds: "I am thrilled to join Bryan, Garnier & Co, and I am looking forward to working with its first class tech corporate finance team which is renowned in the market for its deep sector knowledge and strong client commitment".
Charlie is a graduate from the Supaero/ISAE School of Aeronautics and Space where he obtained a Major in System Modelling and Financial Engineering.
Bryan, Garnier & Co hires leading expert in Deep Technologies
MUNICH, November 27, 2017 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is delighted to welcome Professor Dr. Hermann Eul as Senior Advisor to its Smart Industries practice, based in Paris and Munich. Hermann has over 15 years of Deep Technology experience across a range of fields including communication systems, high performance processors, and software intelligence. Hermann will take on the role as Senior Advisor to the franchise across Europe.
Prior to joining Bryan, Garnier & Co, Hermann held senior executive positions at Siemens, Infineon, and Intel. At Siemens, he led business units in mobile infrastructure and semiconductors. During a decade at Infineon, he held several roles including Head of security and chip card ICs, President of the Communication Solutions business, CTO, CMO, EVP, and was also a member of the management board.
During his five years at Intel, Hermann led a worldwide organization focused on hardware, software and connectivity for phones, tablets, Ultrabooks, and mobile devices. He was also Corporate VP, President of the worldwide Mobile & Communications Group, and President and Managing Director of Intel Germany.
Hermann currently holds board roles in numerous Deep Technology companies including the Knowles Corp (acoustic solutions, Itasca USA), Redpine Signals (low power Wifi modules, San Jose USA), Locata Corp (high precision positioning, Australia), and a number of Silicon Valley Start-ups. In addition he has board roles at industry associations (VDE, Germany) and investment funds (Digital Plus Partners, Germany), as well as being an angel investor through the Band of Angels (San Francisco USA), and Sand Hill Angels (Los Altos USA).
Olivier Beaudouin, Partner, Bryan, Garnier & Co comments, “Emerging applications for autonomous and intelligent systems, such as machine vision, machine learning and AI require immense processing speed and power. Software is reaching the limits of its capabilities and is being complemented once again by a wave of innovation in high power high speed processors for specific applications. Hermann brings breadth of experience and a well-established network across relevant B2B markets, including microelectronics, materials, semiconductor / optical convergence, parallel and distributed processing. This will complement Bryan Garnier’s Deep Technology expertise and transactional experience in the space”.
Hermann adds: “I was impressed by Bryan Garnier’s track record of execution, reach and understanding in a confluence of industry spaces that are increasingly demanding higher performance, power and speed from optimized software and processors. I look forward to working with them to help growing companies realize their global ambitions”.
Hermann holds B.Sc., M.Sc., and Ph.D. degrees in Electrical, Electronic and Communications Engineering from Fachochschule, Koblenz, and Ruhr University, Bochum respectively, and held a full chair / professorship in RF Technology and Transmission Systems at Leibniz University Hannover.
The future of retail is now
Analyzing the fast-evolving retail sector, this new white paper explains why physical stores are in surprisingly good health, ‘experiential’ retail is on the rise and why retailers are turning into technology companies.
Download report
Bryan, Garnier & Co hires Phil Walker as Managing Director in its London Healthcare division
LONDON, October, 30 2017 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is proud to announce the hiring of senior banker Phil Walker to join its European Healthcare division in London.
Phil Walker has advised on more than 60 successful transactions including IPOs, secondary fundraisings and M&A in the UK, Europe, Israel and the US. He joins Bryan, Garnier & Co as Managing Director UK Healthcare Corporate Finance.
Phil, British, is a corporate financier and equity capital markets investment banker with 20 years’ experience advising healthcare/life science and high growth technology companies.
Prior to joining Bryan, Garnier & Co, he was Head of Healthcare and Cleantech corporate finance at Zeus Capital Limited. Previously, Phil was a Co-founder of investment banking boutique, Code Securities, which was acquired by Nomura. Prior to Code Securities, he spent five years as a specialist healthcare corporate financier in the WestLB Panmure Life Sciences Group, then Europe's leading healthcare investment bank. Phil qualified as a chartered accountant with Price Waterhouse in 1997.
Phil Walker comments, “I am delighted to have joined Bryan, Garnier & Co. The firm shares my focus and long-term commitment to the healthcare sector and I look forward to building Bryan Garnier’s UK healthcare business to strengthen further the firm’s leading position in continental Europe".
Olivier Garnier, Managing Partner, adds: “I am pleased to have Phil join us to help build our UK business. The quality and the depth of his experience within the UK healthcare community will be a great asset for the team. Phil’s appointment comes after Dominic Wilson and Gary Waanders joined the firm in last month and aims to reinforce the Bryan, Garnier Healthcare franchise in London".
Bryan, Garnier & Co strengthens its Investment Banking team with the hiring of Marc-Antoine Janny as Vice President
PARIS, October 17, 2017 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is delighted to welcome back Marc-Antoine Janny to its European investment banking team, based in Paris.
With over eight years of corporate finance experience in M&A and ECM, Marc-Antoine, will join the firm as Vice President and will be responsible for the origination and execution of private placement and M&A mandates for European growth companies, as well as help Bryan, Garnier & Co to leverage its footprint within its healthcare and TMT practices.
Marc-Antoine worked for Bryan, Garnier & Co as an M&A analyst from 2008 to 2011 when he left to join Michel Dyens & Co. He then founded Canary Street, the first European marketplace dedicated to the distribution of emerging designers in the home decor environment whose assets were acquired by Belgium-based e-commerce company Decovry. In 2015 he joined goetzpartners before moving back to Bryan, Garnier & Co as a Vice President. During his career, he has developed a significant experience in M&A, ECM and fundraising transactions including: Capital increase of Airlinair (subsidiary of Air France), IPO of Integragen, disposal of Vemedia to Industri Kapital, disposal of Russia-based Ekomir Pharma to Valeant and the disposal of Italy-based Sharper Therapeutics to Gruppo Indena della Beffa.
Greg Revenu, Managing Partner, Paris comments: “I am delighted to welcome Marc-Antoine back to the Bryan, Garnier & Co investment banking team. Marc-Antoine has an entrepreneurial mindset having successfully founded, funded, run and sold a start-up and as such brings with him a valuable perspective to best support the founders we advise”.
Marc-Antoine adds: “I am pleased to be back at Bryan, Garnier & Co and have a particular attachment to the firm and the great people working here. I started my career at the company and truly believe in its market positioning, strong track record and deep sector expertise in TMT and Healthcare sectors making it ideal to serve growth companies in Europe. I am looking forward to contributing to its future growth in the European market”.
Marc-Antoine holds a master in Finance from Grenoble Graduate School of Business and Singapore Management University.
Wilson and Waanders join London Healthcare franchise as Managing Directors
LONDON, September 26, 2017 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is proud to announce two new experienced hires to join its European Healthcare division in London.
Dominic Wilson and Gary Waanders have together conducted more than 15 transactions and raised over £370m since early 2014 working on numerous IPOs and secondary fund raisings. They join Bryan, Garnier & Co as Managing Directors and are tasked with leveraging their combined experience in the UK market to further strengthen the bank’s already formidable footprint in the sector across Europe.
Dominic Wilson, British, has a held a variety of positions in the healthcare sector during his long career. He started his financial work as a Healthcare analyst based in New York, for Kleinwort Benson Securities and then moved on to hold numerous senior sales positions in the UK including Head of Sales at Old Mutual Securities, Piper Jaffray Ltd as Principal, European Equity Sales, Arden Partners and, more recently, Nomura Code as Head of Sales before joining Zeus in 2013 as Head of Healthcare Sales. Dominic has a BSc (Hons) in Genetics.
Gary Waanders, Australian, has a long experience of working in the life sciences and financial sectors. Since 2001 he has been an analyst in the City of London where he has previously worked as Director of Healthcare Research at Zeus Capital, Nomura Code Securities and KBC Peel Hunt. He has also worked in industry and academia including two years managing R&D teams at a small biotech company in Canada and six years as a Post-Doctoral Research fellow at the Ludwig Institute for Cancer Research (Lausanne Branch, Switzerland). He holds an MBA (Durham University, UK) and a PhD in Immunology from the Faculty of Medicine, Monash University, Melbourne (Australia).
Dominic Wilson and Gary Waanders comment, “We are delighted to join Bryan, Garnier & Co and to continue to work together. We have known and respected the firm for many years and regard it highly as the leading independent European investment bank specializing in growth companies, particularly in healthcare, a sector to which we and Bryan Garnier share a strong focus and commitment”.
Olivier Garnier, Managing Partner, comments: "I am pleased to welcome Dominic and Gary to our dedicated healthcare franchise, made up of over 20 senior professionals, to continue to build our business as the investment bank of choice for any European healthcare company. Our track record in M&A as well as growth financing built over 20 years of experience, is firmly established in the market.
We are also the most active independent investment bank involved in IPO‘s and follow-ons of European healthcare growth companies on Nasdaq, advising companies such as LDR, Celyad, DBV and Galapagos. Over the last three years, Bryan Garnier has completed over 14 transactions for European healthcare growth companies, raising a total of over $1 billion and including the sale of Symetis to Boston Scientific for $435 million last April".
The promise of blockchain
In our latest white paper we explore and explain blockchain, looking at the cryptocurrency bitcoin, the impact of bitcoin mining on technology, and the implications of blockchain for the payments industry. We also explore the many other applications for blockchain technology.